These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 8328104)
1. [More mesalazine against Crohn disease of the small intestine]. Schaffalitzky de Muckadell OB Ugeskr Laeger; 1993 Jul; 155(29):2286. PubMed ID: 8328104 [No Abstract] [Full Text] [Related]
2. [Diffuse alopecia as side effect of mesalazine therapy in Crohn's disease]. Netzer P Schweiz Med Wochenschr; 1995 Dec; 125(50):2438-42. PubMed ID: 8553032 [TBL] [Abstract][Full Text] [Related]
3. [Mesalazine in Crohn disease]. Linnestad P Tidsskr Nor Laegeforen; 1990 Oct; 110(25):3252. PubMed ID: 2256041 [No Abstract] [Full Text] [Related]
4. [Is preventive drug therapy of recurrent Crohn disease indicated after ileocecal resection?]. Koop I Internist (Berl); 1994 Feb; 35(2):192. PubMed ID: 7908661 [No Abstract] [Full Text] [Related]
8. Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission. Ewe K; Becker K; Ueberschaer B Z Gastroenterol; 1996 Apr; 34(4):225-9. PubMed ID: 8686349 [TBL] [Abstract][Full Text] [Related]
9. Drug insight: aminosalicylates for the treatment of IBD. Nielsen OH; Munck LK Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853 [TBL] [Abstract][Full Text] [Related]
10. Uncoated versus coated 5-aminosalicylic acid in Crohn's disease. Bossi A; Giuliani GE; Del Poggio P; Fenili D; Ragaini S Lancet; 1989 Feb; 1(8632):276. PubMed ID: 2563434 [No Abstract] [Full Text] [Related]
11. Kawasaki-like syndrome after treatment with mesalazine. Waanders H; Thompson J Am J Gastroenterol; 1991 Feb; 86(2):219-21. PubMed ID: 1992637 [TBL] [Abstract][Full Text] [Related]
12. Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group. Hanauer SB; Krawitt EL; Robinson M; Rick GG; Safdi MA Am J Gastroenterol; 1993 Sep; 88(9):1343-51. PubMed ID: 8362827 [TBL] [Abstract][Full Text] [Related]
13. Treatment of Crohn's disease with 5-ASA. Katz J Am J Gastroenterol; 1993 Sep; 88(9):1315-7. PubMed ID: 8362823 [No Abstract] [Full Text] [Related]
14. Asacol in inflammatory bowel disease. Oakes RA N Z Med J; 1987 May; 100(824):325. PubMed ID: 3451096 [No Abstract] [Full Text] [Related]
15. Mesalazine as maintenance treatment in Crohn's disease. Vos J; Lesterhuis W Gastroenterology; 1994 Feb; 106(2):553-4. PubMed ID: 8299923 [No Abstract] [Full Text] [Related]
18. [Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine]. Glintborg B Ugeskr Laeger; 2000 Aug; 162(34):4553-4. PubMed ID: 10981226 [TBL] [Abstract][Full Text] [Related]
19. Equimolar doses of balsalazide and mesalamine: are we comparing apples and oranges? Farrell RJ; Peppercorn MA Am J Gastroenterol; 2002 Jun; 97(6):1283-5. PubMed ID: 12094839 [No Abstract] [Full Text] [Related]
20. [Acute pancreatitis induced by drugs derived from 5-aminosalicylic acid: case report and review of the literature]. Decocq G; Gras-Champel V; Vrolant-Mille C; Delcenserie R; Sauvé L; Masson H; Andréjak M Therapie; 1999; 54(1):41-8. PubMed ID: 10216421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]